XML 12 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Mezzanine Equity and Stockholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Total
Preferred Stock [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Additional Paid In Capital [Member]
Accumulated Other Comprehensive (Loss) Income [Member]
Retained (Deficit) [Member]
Balance at Dec. 31, 2023 $ (46,206) $ 83,458 $ 210 $ 94,067 $ 2,365 $ (142,848)
Balance (Shares) at Dec. 31, 2023   85,412 17,903,437      
Net income (loss) (110,440)         (110,440)
Other comprehensive income (loss) (2,281)       (2,281)  
Accretion of Series C preferred shares issuance costs (431)          
Accretion of Series C preferred shares issuance costs (431) $ 431       (431)
Restricted stock awards     $ 8 (8)    
Restricted stock awards, shares     774,796      
Employee stock settlement (40)     (40)    
Employee stock settlement, shares     (14,615)      
Forfeiture of restricted stock awards     $ (1) 1    
Forfeiture of restricted stock awards, shares     (106,790)      
Exercise of stock options and appreciation rights (751)   $ (3) (748)    
Exercise of stock options and appreciation rights, Shares     328,010      
Stock-based compensation recognized 2,330     2,330    
Balance at Sep. 30, 2024 (156,317) $ 83,889 $ 220 97,098 84 (253,719)
Balance (Shares) at Sep. 30, 2024   85,412 18,884,838      
Balance at Jun. 30, 2024 (48,829) $ 83,745 $ 220 96,312 1,168 (146,529)
Balance (Shares) at Jun. 30, 2024   85,412 18,873,850      
Net income (loss) (107,046)         (107,046)
Other comprehensive income (loss) (1,084)       (1,084) 0
Accretion of Series C preferred shares issuance costs (144)          
Accretion of Series C preferred shares issuance costs (144) $ 144       (144)
Exercise of stock options and appreciation rights (18)   $ 0 (18)    
Exercise of stock options and appreciation rights, Shares     10,988      
Stock-based compensation recognized 804     804    
Balance at Sep. 30, 2024 (156,317) $ 83,889 $ 220 97,098 84 (253,719)
Balance (Shares) at Sep. 30, 2024   85,412 18,884,838      
Balance at Dec. 31, 2024 $ (150,273)   $ 221 69,404 721 (220,619)
Balance (Shares) at Dec. 31, 2024 18,960,608   18,960,608      
Net income (loss) $ 54,682         54,682
Other comprehensive income (loss) 2,115       2,115  
Accretion of Series C preferred shares issuance costs 0          
Restricted stock awards     $ 2 (2)    
Restricted stock awards, shares     195,975      
Employee stock settlement (487)   $ (1) (486)    
Employee stock settlement, shares     (50,010)      
Forfeiture of restricted stock awards     $ (1) 1    
Forfeiture of restricted stock awards, shares     (50,326)      
Exercise of stock options and appreciation rights (45)     (45)    
Exercise of stock options and appreciation rights, Shares     20,839      
Stock-based compensation recognized 3,134     3,134    
Balance at Sep. 30, 2025 $ (90,874)   $ 221 72,006 2,836 (165,937)
Balance (Shares) at Sep. 30, 2025 19,077,086   19,077,086      
Balance at Jun. 30, 2025 $ (83,462)   $ 222 71,572 3,236 (158,492)
Balance (Shares) at Jun. 30, 2025     19,127,412      
Net income (loss) (7,445)         (7,445)
Other comprehensive income (loss) (400)       (400) 0
Accretion of Series C preferred shares issuance costs 0          
Forfeiture of restricted stock awards     $ (1) 1    
Forfeiture of restricted stock awards, shares     (50,326)      
Stock-based compensation recognized 433     433    
Balance at Sep. 30, 2025 $ (90,874)   $ 221 $ 72,006 $ 2,836 $ (165,937)
Balance (Shares) at Sep. 30, 2025 19,077,086   19,077,086